Global Artificial Intelligence Diagnostics market size is predicted to grow from US$ 7101 million in 2025 to US$ 27916 million in 2032; it is expected to grow at a CAGR of 21.6% from 2026 to 2032.

Global Artificial Intelligence Diagnostics Market Size, Share and Analysis 2026-32

The global Artificial Intelligence Diagnostics market size is predicted to grow from US$ 7101 million in 2025 to US$ 27916 million in 2032; it is expected to grow at a CAGR of 21.6% from 2026 to 2032. Artificial Intelligence Diagnostics refers to regulated software systems that apply machine learning, deep learning, and advanced analytics to clinical data in order to support or deliver diagnostic decisions. Unlike general clinical analytics, AI diagnostics are designed to influence medical judgment by identifying disease, assessing severity, or recommending diagnostic conclusions based on inputs such as medical imaging, physiological signals (e.g., ECG, EEG), ophthalmic images, laboratory patterns, and multi-modal clinical data. Most solutions are commercialized as Software as a Medical Device (SaMD) and operate under strict regulatory frameworks such as FDA clearance or CE marking. AI diagnostics do not replace physicians but function as decision-support or physician-in-the-loop systems, improving diagnostic accuracy, speed, and consistency across healthcare settings. Artificial Intelligence Diagnostics refers to regulated software systems that apply machine learning, deep learning, and advanced analytics to The market can be classified by diagnostic data type (imaging-based, physiological signal-based, ophthalmic, multi-modal), by diagnostic role (screening, diagnostic assistance, automated diagnosis, severity assessment, therapy guidance), by clinical specialty (radiology, cardiology, neurology, ophthalmology, oncology, primary care), by deployment model (standalone SaMD, cloud SaaS, device-embedded, edge or wearable-based), and by regulatory/commercial type (FDA/CE-cleared diagnostic AI, clinical decision support, screening-only solutions). Upstream players include medical device OEMs, sensor and imaging hardware suppliers, cloud and GPU infrastructure providers, and healthcare institutions contributing annotated clinical datasets. Midstream consists of AI diagnostics developers responsible for algorithm design, clinical validation, regulatory approval, and system integration with hospital IT. Downstream customers are hospitals, diagnostic centers, physician groups, and population-health programs, purchasing AI diagnostics through enterprise software contracts, bundled device sales, or subscription platforms. Key costs arise from data acquisition and labeling, clinical trials, regulatory compliance, and continuous model maintenance. Due to software-driven economics, gross margins typically range from 65% to 80%. Transactions are dominated by subscription SaaS, per-use pricing, and multi-year enterprise licenses, increasingly bundled with devices or workflow platforms. Market trends include rapid expansion beyond radiology into cardiology and primary care, accelerated regulatory approvals, consolidation through M&A, and rising adoption driven by clinician shortages and value-based care models. Infinity Market Research newest research report, the Artificial Intelligence Diagnostics Industry Forecast looks at past sales and reviews total world Artificial Intelligence Diagnostics sales in 2025, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Diagnostics sales for 2026 through 2032. With Artificial Intelligence Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Diagnostics industry. This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Artificial Intelligence Diagnostics market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Diagnostics. This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Diagnostics market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Services &nbsp;&nbsp;&nbsp; Software &nbsp;&nbsp;&nbsp; Hardware &nbsp;&nbsp;&nbsp; Segmentation by Diagnostic Data Type: &nbsp;&nbsp;&nbsp; Medical Imagingbased &nbsp;&nbsp;&nbsp; Physiological Signalsbased &nbsp;&nbsp;&nbsp; Ophthalmic Imagingbased &nbsp;&nbsp;&nbsp; Others &nbsp;&nbsp;&nbsp; Segmentation by Deployment & Delivery: &nbsp;&nbsp;&nbsp; On-prem &nbsp;&nbsp;&nbsp; Cloud SaaS &nbsp;&nbsp;&nbsp; Edge / Embedded &nbsp;&nbsp;&nbsp; Hybrid &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Radiology &nbsp;&nbsp;&nbsp; Oncology &nbsp;&nbsp;&nbsp; Neurology &nbsp;&nbsp;&nbsp; Cardiology &nbsp;&nbsp;&nbsp; Chest & Lungs &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Butterfly Network &nbsp;&nbsp;&nbsp; Merative &nbsp;&nbsp;&nbsp; Tempus &nbsp;&nbsp;&nbsp; RetinAi &nbsp;&nbsp;&nbsp; Nanox &nbsp;&nbsp;&nbsp; Lunit &nbsp;&nbsp;&nbsp; DiA Imaging &nbsp;&nbsp;&nbsp; Subtle Medical &nbsp;&nbsp;&nbsp; BrainMiner &nbsp;&nbsp;&nbsp; GE &nbsp;&nbsp;&nbsp; Siemens &nbsp;&nbsp;&nbsp; Aidoc &nbsp;&nbsp;&nbsp; Imagen Technologies, Inc. &nbsp;&nbsp;&nbsp; VUNO, Inc. &nbsp;&nbsp;&nbsp; Digital Diagnostics &nbsp;&nbsp;&nbsp; NeuraSignal &nbsp;&nbsp;&nbsp; Riverain Technologies, LLC &nbsp;&nbsp;&nbsp; Philips &nbsp;&nbsp;&nbsp; Microsoft &nbsp;&nbsp;&nbsp; Viz.ai &nbsp;&nbsp;&nbsp; RapidAI &nbsp;&nbsp;&nbsp; Canon Medical &nbsp;&nbsp;&nbsp; Enlitic &nbsp;&nbsp;&nbsp; BioMind &nbsp;&nbsp;&nbsp; ANNALISE-AI PTY LTD &nbsp;&nbsp;&nbsp; icometrix &nbsp;&nbsp;&nbsp; KONFOONG BIOTECH INTERNATIONAL CO., LTD?KFBIO?

Report	Global Artificial Intelligence Diagnostics Market Growth (Status and Outlook) 2026-2032
Selected License	Multi ID: ILR1144

Buyer Information

Order Summary